Haleos Labs (NSE:HALEOSLABS) Asset Turnover: 0.17 (As of Mar. 2026)


NSE:HALEOSLABS Haleos Labs Ltd NSE:HALEOSLABS
76 GF Score
Price ₹1,596.60
GF Value ₹1,124.05
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Haleos Labs Asset Turnover?

Haleos Labs NSE:HALEOSLABS +3.22% 76 Asset Turnover is 0.17 as of Mar. 2026. GuruFocus rates NSE:HALEOSLABS with a GF Score™ of 76/100 and a GF Value™ of ₹1,124.05 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Haleos Labs's Revenue for the three months ended in Mar. 2026 was ₹751 Mil. Haleos Labs's Total Assets for the quarter that ended in Mar. 2026 was ₹4,544 Mil. Therefore, Haleos Labs's Asset Turnover for the quarter that ended in Mar. 2026 was 0.17.

Asset Turnover is linked to ROE % through Du Pont Formula. Haleos Labs's annualized ROE % for the quarter that ended in Mar. 2026 was 0.82%. It is also linked to ROA % through Du Pont Formula. Haleos Labs's annualized ROA % for the quarter that ended in Mar. 2026 was 0.38%.


Haleos Labs  (NSE:HALEOSLABS) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Haleos Labs's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=17.428/2135.478
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(17.428 / 3005.564)*(3005.564 / 4544.084)*(4544.084/ 2135.478)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.58 %*0.6614*2.1279
=ROA %*Equity Multiplier
=0.38 %*2.1279
=0.82 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Haleos Labs's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=17.428/4544.084
=(Net Income / Revenue)*(Revenue / Total Assets)
=(17.428 / 3005.564)*(3005.564 / 4544.084)
=Net Margin %*Asset Turnover
=0.58 %*0.6614
=0.38 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Haleos Labs Asset Turnover Related Terms


Haleos Labs Asset Turnover Historical Data

* Premium members only.

The historical data trend for Haleos Labs's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleos Labs Asset Turnover Chart

Haleos Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.05 0.83 0.76 0.88 0.79

Haleos Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.21 0.21 0.24 0.17

NSE:HALEOSLABS vs VRTX, REGN, ALNY: Asset Turnover Comparison

For the Biotechnology subindustry, Haleos Labs's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haleos Labs Asset Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Haleos Labs's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Haleos Labs's Asset Turnover falls into.


NSE:HALEOSLABS
76GF Score
Haleos Labs Ltd NSE:HALEOSLABS
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleos Labs Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Haleos Labs's Asset Turnover for the fiscal year that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2026 )/( (Total Assets (A: Mar. 2025 )+Total Assets (A: Mar. 2026 ))/ count )
=3337.945/( (3899.911+4544.084)/ 2 )
=3337.945/4221.9975
=0.79

Haleos Labs's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=751.391/( (0+4544.084)/ 1 )
=751.391/4544.084
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.17 mean?
Haleos Labs (NSE:HALEOSLABS) has a Asset Turnover of 0.17 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Haleos Labs and its competitors.
Is Haleos Labs' Asset Turnover too high?
Haleos Labs' current Asset Turnover is 0.17. Overall, Haleos Labs has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Haleos Labs' Asset Turnover compare to VRTX and REGN?
Haleos Labs' Asset Turnover of 0.17 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Biotechnology company?
A good Asset Turnover depends on the Biotechnology industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Haleos Labs and its competitors. Haleos Labs's current Asset Turnover is 0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleos Labs stock overvalued right now?
Based on GuruFocus' analysis, Haleos Labs (NSE:HALEOSLABS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,124.05, compared to a current price of ₹1,596.60 — trading 42% above its estimated fair value. The current Asset Turnover is 0.17. Haleos Labs' overall GF Score™ is 76/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Haleos Labs (NSE:HALEOSLABS), the current Asset Turnover is 0.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleos Labs (NSE:HALEOSLABS) Overvalued in 2026?

Based on GuruFocus' analysis, Haleos Labs stock appears to be overvalued. The current stock price of ₹1,596.60 is trading 42% above its estimated GF Value™ of ₹1,124.05. GuruFocus considers Haleos Labs to be Significantly Overvalued.

Key valuation signals for NSE:HALEOSLABS:

  • Asset Turnover: 0.17
  • GF Value™: ₹1,124.05 vs. price of ₹1,596.60 (42% above fair value)
  • GF Score™: 76/100 with 10 warning signs

No single metric tells the full story. See the NSE:HALEOSLABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Haleos Labs Business Description

Other Exchanges 540679:India
Address Road Number 71, Plot Number 19 - III, Opposite Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad, TG, IND, 500096
Haleos Labs Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
76GF Score

Get the complete analysis for NSE:HALEOSLABS

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,596.60
Price
₹1,124.05
GF Value